Data Readout Anticipated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Readout Anticipated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Readout Anticipated Today - Breaking & Trending Today

Yumanity Therapeutics : Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 Closed $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Form 8-K

Published: May 11, 2023

Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 ... | May 11, 2023

Source: marketscreener.com

Related Topics:

Myriam ChalabiMichaela CurranPatricia LorussoShawn IadonatoJohn MullalyEvany YuJacques BouchyLifesci AdvisorsKineta IncNetherlands Cancer InstituteClinical Research DivisionFred Hutchinson Cancer ConsortiumInvestor Relations Business DevelopmentClinical ResearchFred Hutchinson Cancer CenterDosed First PatientAdvanced Solid TumorsData Readout AnticipatedRegistered Direct Offering Priced At The MarketNasdaq RulesChief Executive OfficerScientific Advisory BoardSection HeadCancer MedicineMedical Director